Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2025-12-24 @ 11:35 PM
NCT ID:
NCT05705856
Eligibility Criteria:
Inclusion Criteria:
* Agree to participate in the study
* With active Crohn's disease
* Undergoing Ustekinumab dose intensification with at least two or more intravenous infusions at the discretion of the treating physician
* HBI ≥ 5 before Ustekinumab therapy
* Over 18 years of age
Exclusion Criteria:
* Who had received Ustekinumab for an indication
* Pregnant or nursing
* L4 type
* History of enterectomy or enterostomy related to disease
* Who used total enteral nutrition for more than 2 weeks due to complications such as obstruction, abscess and perforation after starting Ustekinumab therapy
* Pregnant and lactating women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05705856
Study Brief:
Protocol Section:
NCT05705856